Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Cook launches new sizes of peripheral DES

This article was originally published in Clinica

Executive Summary

Cook Medical has launched new sizes of its Zilver PTX drug-eluting peripheral stent, designed to treat peripheral artery disease in the superficial femoral artery, in Europe. The paclitaxel-coated device will now be available in lengths up to 120mm and with a 6 French diameter delivery system. Recently clinical data showed that the device causes a 50% reduction in restenosis compared with bare-metal stenting and allows 74.8% primary patency at two years (www.clinica.co.uk, 18 January 2011). Andy Förster, EMEA manager for Cook's peripheral intervention business unit, said: "Since the announcement of this data, adoption of the Zilver PTX has greatly increased." Zilver PTX is not yet approved in the US.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT096890

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel